1. Home
  2. ADVB vs ADXN Comparison

ADVB vs ADXN Comparison

Compare ADVB & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$4.59

Market Cap

7.4M

Sector

Health Care

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

HOLD

Current Price

$5.79

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADVB
ADXN
Founded
2014
2002
Country
United States
Switzerland
Employees
31
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
8.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ADVB
ADXN
Price
$4.59
$5.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.9K
4.0K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
$1.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$5.41
52 Week High
$7.70
$12.05

Technical Indicators

Market Signals
Indicator
ADVB
ADXN
Relative Strength Index (RSI) 55.38 40.67
Support Level $3.71 $5.75
Resistance Level $5.59 $7.37
Average True Range (ATR) 0.47 0.54
MACD 0.05 -0.04
Stochastic Oscillator 78.57 12.24

Price Performance

Historical Comparison
ADVB
ADXN

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: